ForMune vs Navigo Proteins GmbH

ForMune logo

ForMune

Crafting Therapeutic Vaccines with Protein Extra Domain A of Fibronectin for Licensure to Pharma and Marketing Firms

est. 2012

VS
Navigo Proteins GmbH logo

Navigo Proteins GmbH

Unique Affinity Solutions for Biopharmaceutical Manufacturing and Biotherapeutics

43 employees · est. 2017 · Germany

ForMune is the older company (2012 vs 2017).

Side-by-Side Comparison

ForMune Navigo Proteins GmbH
Founded
2012 older 2017
Headquarters
Not tracked yet Germany
Employees
Not tracked yet 43
Industry
Biotechnology, Health Care, Health and Wellness Biotechnology, Pharmaceutical
Funding Stage
Venture round Not tracked yet
Total Funding
$4.40M Not tracked yet
Funding Rounds
1 Not tracked yet
Taxonomy
Therapeutic VaccinesProtein Extra Domain AFibronectinPharmaceutical CompaniesMarketing CompaniesDrug Development Protein EngineeringAffinity LigandsBiopharmaceuticalsScaffold ProteinsPrecision MedicineDownstream Processing +9
Website
formune.es navigo-proteins.com
ForMune logo

About ForMune

ForMune, founded in 2012, is a biotechnology and healthcare startup that focuses on developing therapeutic vaccines using protein Extra Domain A of fibronectin. The company's slogan, "Crafting Therapeutic Vaccines with Protein Extra Domain A of Fibronectin for Licensure to Pharma and Marketing Firms...

Navigo Proteins GmbH logo

About Navigo Proteins GmbH

Navigo Proteins GmbH is a biotech startup based in Germany, founded in 2017, specializing in the discovery and development of novel scaffold proteins-based affinity ligands for biopharmaceutical manufacturing and biotherapeutics. The company's unique protein engineering expertise has resulted in the...

Also comparing in this category

We will tell you when either one moves

BounceWatch watches ForMune and Navigo Proteins GmbH for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.

Get notified when ForMune or Navigo Proteins GmbH moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Frequently Asked Questions

ForMune was founded in 2012. ForMune, founded in 2012, is a biotechnology and healthcare startup that focuses on developing therapeutic vaccines using protein Extra Domain A of fibronectin. The company's slogan, "Crafting Therape. Navigo Proteins GmbH was founded in 2017, based in Germany, with 43 employees. Navigo Proteins GmbH is a biotech startup based in Germany, founded in 2017, specializing in the discovery and development of novel scaffold proteins-based affinity ligands for biopharmaceutical manuf.
ForMune has raised $4.40M and Navigo Proteins GmbH no disclosed funding. Latest stage: ForMune Venture round.
Both work in Biotechnology.

Compare ForMune with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at ForMune on 13 Sep 2024, and Navigo Proteins GmbH on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes